NEUROKININ A

ID: ALA217406

Max Phase: Preclinical

Molecular Formula: C50H80N14O14S

Molecular Weight: 1133.34

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(C)C)C(N)=O

Standard InChI:  InChI=1S/C50H80N14O14S/c1-26(2)18-34(45(73)58-32(42(53)70)15-17-79-6)57-38(67)23-55-49(77)40(27(3)4)63-47(75)35(19-29-12-8-7-9-13-29)60-48(76)37(24-65)62-46(74)36(21-39(68)69)61-50(78)41(28(5)66)64-44(72)33(14-10-11-16-51)59-43(71)31(52)20-30-22-54-25-56-30/h7-9,12-13,22,25-28,31-37,40-41,65-66H,10-11,14-21,23-24,51-52H2,1-6H3,(H2,53,70)(H,54,56)(H,55,77)(H,57,67)(H,58,73)(H,59,71)(H,60,76)(H,61,78)(H,62,74)(H,63,75)(H,64,72)(H,68,69)/t28-,31+,32+,33+,34+,35+,36+,37+,40+,41+/m1/s1

Standard InChI Key:  HEAUFJZALFKPBA-JPQUDPSNSA-N

Associated Targets(Human)

Neurokinin 1 receptor 6273 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neurokinin 2 receptor 3341 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neurokinin 3 receptor 1696 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Neurokinin 1 receptor 881 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neurokinin 2 receptor 373 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neurokinin 3 receptor 158 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

CHO 4503 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neurokinin 2 receptor 349 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cavia porcellus 23802 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cricetinae gen. sp. 3197 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neurokinin 2 receptor 128 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Neurokinin 1 receptor 938 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1133.34Molecular Weight (Monoisotopic): 1132.5699AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Laufer R, Gilon C, Chorev M, Selinger Z..  (1986)  [pGlu6,Pro9]SP6-11, a selective agonist for the substance P P-receptor subtype.,  29  (7): [PMID:2433445] [10.1021/jm00157a029]
2. Harrison T, Korsgaard MP, Swain CJ, Cascieri MA, Sadowski S, Seabrook GR..  (1998)  High affinity, selective neurokinin 2 and neurokinin 3 receptor antagonists from a common structural template.,  (11): [PMID:9871763] [10.1016/s0960-894x(98)00215-7]
3. Karoyan P, Sagan S, Clodic G, Lavielle S, Chassaing G..  (1998)  Asymmetric synthesis of Boc-N-methyl-p-benzoyl-phenylalanine. Preparation of a photoreactive antagonist of substance P.,  (11): [PMID:9871768] [10.1016/s0960-894x(98)00219-4]
4. Neugebauer W, Elliott P, Cuello AC, Escher E..  (1988)  Synthesis and immunological evaluation of N-terminal, noncrossreactive tachykinin antigens.,  31  (10): [PMID:2459385] [10.1021/jm00118a007]
5. Gembitsky DS, Murnin M, Otvös FL, Allen J, Murphy RF, Lovas S..  (1999)  Importance of the aromatic residue at position 6 of [Nle(10)]neurokinin A(4-10) for binding to the NK-2 receptor and receptor activation.,  42  (15): [PMID:10425111] [10.1021/jm9807151]
6. Rosen T, Seeger TF, McLean S, Desai MC, Guarino KJ, Bryce D, Pratt K, Heym J, Chalabi PM, Windels JH..  (1993)  Synthesis, in vitro binding profile, and autoradiographic analysis of [3H]-cis-3-[(2-methoxybenzyl)amino]-2-phenylpiperidine, a highly potent and selective nonpeptide substance P receptor antagonist radioligand.,  36  (21): [PMID:7693945] [10.1021/jm00073a022]
7. Giolitti A, Altamura M, Bellucci F, Giannotti D, Meini S, Patacchini R, Rotondaro L, Zappitelli S, Maggi CA..  (2002)  Monocyclic human tachykinin NK-2 receptor antagonists as evolution of a potent bicyclic antagonist: QSAR and site-directed mutagenesis studies.,  45  (16): [PMID:12139452] [10.1021/jm011127h]
8. Harbeson SL, Shatzer SA, Le TB, Buck SH..  (1992)  A new class of high affinity ligands for the neurokinin A NK2 receptor: psi (CH2NR) reduced peptide bond analogues of neurokinin A4-10.,  35  (21): [PMID:1331450] [10.1021/jm00099a024]
9. Deal MJ, Hagan RM, Ireland SJ, Jordan CC, McElroy AB, Porter B, Ross BC, Stephens-Smith M, Ward P..  (1992)  Conformationally constrained tachykinin analogues: potent and highly selective neurokinin NK-2 receptor agonists.,  35  (22): [PMID:1331460] [10.1021/jm00100a027]
10. Wang J, Bray AM, DiPasquale AJ, Maeji N, Geysen H.  (1993)  Application of the multipin peptide synthesis technique for peptide receptor binding studies: Substance P as A model system,  (3): [10.1016/S0960-894X(01)80229-8]
11. Howson W, Hodgson J, Richardson R, Walton L, Guard S, Watling K.  (1992)  An SAR study for the non-peptide substance P receptor (NK1) antagonist, CP-96,345.,  (6): [10.1016/S0960-894X(01)81197-5]
12. Singh P, Hurrell CR, Findlay JB, Fishwick CW.  (1997)  Two novel amino acid derivatives containing side-chain thioamides for the synthesis of photoactivatable peptides,  (6): [10.1016/S0960-894X(97)00088-7]
13. Valant C, Maillet E, Bourguignon JJ, Bucher B, Utard V, Galzi JL, Hibert M..  (2009)  Allosteric functional switch of neurokinin A-mediated signaling at the neurokinin NK2 receptor: structural exploration.,  52  (19): [PMID:19746979] [10.1021/jm900671k]
14. Ma Z, Du L, Li M..  (2014)  Toward fluorescent probes for G-protein-coupled receptors (GPCRs).,  57  (20): [PMID:24983484] [10.1021/jm401823z]

Source